Buscar
Mostrando ítems 31-40 de 768
Antiviral activity of chilean medicinal plant extracts
(John Wiley & Sons Ltd., 2007)
Use of small interfering RNA (siRNA) as a viral replication inhibitor of Human Herpesvirus 1 in BALB/C mice with keratoconjuntivitis
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2018)
El semen ejerce un paradójico efecto adyuvante sobre la respuesta inmune anti HSV-2Semen induces a paradoxical adjuvant effect on anti-HSV-2 immune response
(2019-03-29)
El semen es el principal vector de un amplio grupo de enfermedades infecciosas transmitidas sexualmente (ETS), que causan anualmente millones de muertes en el mundo. Además, el semen induce una variedad de acciones biológicas ...
Novel variants of human herpesvirus 2 from Brazilian HIV-1 coinfected subjects
(Fundação Oswaldo Cruz. Instituto Oswaldo Cruz, 2018)
Evaluation of the immunogenicity of a recombinant HSV-1 vector expressing human group C rotavirus VP6 protein
(Elsevier Science, 2018-06)
Group C Rotavirus (RVC) has been associated globally with sporadic outbreaks of gastroenteritis in children and adults. RVC also infects animals, and interspecies transmission has been reported as well as its zoonotic ...
Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate
(Fundação Oswaldo Cruz. Instituto Oswaldo Cruz., 2018)
Herpes Simplex Virus Type 1 Neuronal Infection Elicits Cellular and Molecular Mechanisms of Neuroinflammation and Neurodegeneration in in vitro and in vivo Mice Models
(2017)
Herpes simplex virus type 1 (HSV-1) is a neurotropic virus able to establish a persistent latent infection in the host. Herpes simplex encephalitis (HSE) is associated with a high mortality rate and significant neurological, ...
High prevalence of Alphaherpes virus 2 (HSV-2) positivity in prisons from Midwest Brazil: a cross-sectional study
(BMC Infectious Diseases, 2021)
Immunomodulatory activity of an anti-HSV-1 synthetic stigmastane analog
(Elsevier, 2012-11)
Many viral infections are associated with the development of immunopathologies and autoimmune diseases, which are of difficult treatment and for which no vaccines are yet available. Obtaining compounds that conjugate both ...